2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm: The efficiency of group cognitive rehabilitation to patients with Parkinson’s disease in comparison to relaxation therapy: pilot data

V. Plzáková, D. Enström, T. Nikolai (Prague, Czech Republic)

Non-Pharmacological Interventions · Les Muses Terrace, Level 3

1:15pm-2:45pm: The frequency of lower urinary tract symptoms in patients with Parkinson’s disease and Clinical efficacy of istradefylline

Y. Higashi, M. Tabata, T. Tabuchi (Himeji, Japan)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: The impact of non-motor symptoms on the quality of life of patients with Parkinson’s disease depending on its stages

K. Abdurakhmonova, G. Rakhimbaeva (Tashkent, Uzbekistan)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: The influence of baseline body mass index on cognitive decline in Parkinson’s disease

SY. Kang, HS. Yoo, SJ. Chung, YH. Sohn, PH. Lee (Seoul, Republic of Korea)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: The influence of deep brain stimulation on the Parkinson’s disease brain: functional improvement correlates with increased alpha2 and beta band functional connectivity

L. Boon, W. Potters, A. Hillebrand, R. de Bie, M. Bot, R. Schuurman, C. Stam, F. van Rootselaar, H. Berendse (Amsterdam, Netherlands)

Surgical Therapy · Les Muses Terrace, Level 3

1:15pm-2:45pm: The influence of physical activities on cognition in small group of Parkinson’s Disease patients

J. Silva, M. Pereira, L. Piovesara, P. Azevedo, F. Cendes, A. D'Abreu, R. Guimarães (Campinas, Brazil)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: The Influence of Sociodemographic Factors on Post-DBS Impulse Control Symptom Severity in Parkinson’s Disease

H. Combs, A. Strutt, J. Jimenez-Shahed, N. Niemann, A. Viswanathan, M. York (Houston, TX, USA)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: The interaction between iron metabolism and inflammation in Parkinson´s disease: an in vivo and post mortem study

A. Martín-Bastida, B. Tilley, T. Alireza, S. Gentleman, D. Dexter, R. Ward (London, United Kingdom)

Physiology and Pathophysiology · Les Muses, Level 3

1:15pm-2:45pm: The interplay between cholinergic activity, attention, and turning in Parkinson’s disease

R. Morris, D. Martini, G. Mcbarron, M. Mancini, F. Horak (Portland, OR, USA)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: The Level of Neuroendocrine Hormones in Parkinson´s Disease and their Potential Role as Biomarkers : A Pilot Study

J. Kauffmann, M. Unger, G. Giebel, D. Grün, K. Faßbender, M. Fousse (Homburg, Germany)

Physiology and Pathophysiology · Les Muses, Level 3